Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A new approach to toxicity testing
October 2020
SHARING OPTIONS:

WINSTON-SALEM, N.C.—As part of the Innovation Quarter's iQ Healthtech Labs, the Wake Forest Institute for Regenerative Medicine (WFIRM) and Oracle Health Sciences have joined forces to establish a consortium of industry, government and academia members to investigate new approaches to confirming the safety of drug candidates before they enter human trials. The collaboration will apply WFIRM's Body-on-a-Chip technology to assess drug toxicity in a variety of human tissues, and the resulting data will be analyzed with machine learning technology being co-developed by Oracle Labs and Oracle for Research.
 
“Being able to create approaches to medicine that take into account an individual's unique genetic makeup is critical in today's world of medicine,” said Jane Shen, head of sector development for the Innovation Quarter. “That's why iQ Healthtech Labs is focused on creating partnerships like this one with WFIRM and Oracle that bring together powerful leaders to advance innovative solutions.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.